It doesn’t take a rocket ― er, dick scientist ― to know that it’s not just whiskey that causes whiskey dick. Vodka drinkers ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease ...

Detailed price information for Cspc Pharmaceuticals Group Ltd (CHJTF) from The Globe and Mail including charting and trades.

Mineralys (MLYS) is transitioning to a pre-commercial stage, supported by robust Phase 3 data and a strengthened cash ...

AstraZeneca notes baxdrostat shows reduction in systolic blood pressure in phase III of uncontrolled or resistant hypertension: Our Bureau, Bengaluru Monday, January 5, 2026, 18:0 ...

Boehringer Ingelheim has unveiled its second kidney-focused collaboration in recent weeks, this time penning a ...

The authors conclude that lorundrostat shows promise as an effective blood pressure–lowering therapy for patients with ...

Formal written minutes from the U.S. FDA confirms no major concerns identified for the planned Phase 3 PANDA study of ...

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...

An announcement from Mineralys Therapeutics, Inc. ( ($MLYS) ) is now available. On January 6, 2026, Mineralys Therapeutics provided a corporate ...

Drinking enough water may reduce period pain, bloating, and fatigue. Learn how hydration influences hormones and menstrual ...

The year saw the emergence of a new version of an old drug that proved beneficial in patients who have heart failure with ...